These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 2316222)

  • 1. [Hemolyzing antibodies to markers of the P blood factor system as a problem in blood transfusion and pregnancy. With reference to serology, biochemistry and genetics].
    Pausch V; Speiser P; Michl U; Höcker P; Engelfriet CP
    Wien Klin Wochenschr; 1990 Feb; 102(3):80-90. PubMed ID: 2316222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoglobulin subclass (IgG3) restriction of anti-P and anti-Pk antibodies in patients of the rare p blood group.
    Söderström T; Enskog A; Samuelsson BE; Cedergren B
    J Immunol; 1985 Jan; 134(1):1-3. PubMed ID: 3964810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pregnancy with an extremely rare P blood group with anti-PP1Pk].
    Strowitzki T; Wiedemann R; Heim MU; Brehm G; Roithmeier A
    Geburtshilfe Frauenheilkd; 1991 Sep; 51(9):710-3. PubMed ID: 1743470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Status of Kell incompatibility in a 15-year retrospective study of mother-child serology in clinical records].
    Schönitzer D
    Infusionsther Klin Ernahr; 1987 Apr; 14 Suppl 2():3-9. PubMed ID: 3596796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of fatal hemolytic disease of the newborn associated with-D-/-D-phenotype.
    Han KS; Kim HC; Han KS; Shim WS
    Am J Perinatol; 1997 Sep; 14(8):495-7. PubMed ID: 9376014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A rare blood group: p phenotype].
    De La Vega Elena CD; Hellberg A; Bonetti S; Gonzalez CA; Chialina S; Raillon MA; Pivetta MA; Solis EA; Olsson ML
    Medicina (B Aires); 2009; 69(6):651-4. PubMed ID: 20053607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
    Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fetal hemolytic disease in a patient immunized by six antibodies: diagnosis and treatment].
    Tantalo V; Rossi E; Gianotti GA; Morotti R; Zuliani G; Buscaglia M; Galligani M
    Ann Ostet Ginecol Med Perinat; 1990; 111(5):321-5. PubMed ID: 2092607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmapheresis for the treatment of repeated early pregnancy wastage associated with anti-P.
    Rock JA; Shirey RS; Braine HG; Ness PM; Kickler TS; Niebyl JR
    Obstet Gynecol; 1985 Sep; 66(3 Suppl):57S-60S. PubMed ID: 4022518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunochemical observations on the human blood group P system.
    Watkins WM; Morgan WT
    J Immunogenet; 1976 Feb; 3(1):15-27. PubMed ID: 932463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The first example of anti-Dia antibody in Poland.
    Kuśnierz-Alejska G; Bochenek S; Zukowska B
    Mater Med Pol; 1990; 22(1):15-6. PubMed ID: 2079854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Haemolytic disease of the newborn--from a mother with anti-Kell, anti-E and anti-Vel anti-erythrocyte alloantibodies].
    Vućinović M; Jadrić H; Karelović D; Roje D; Haspl-Hundrić Z; Hrgović Z; Vućinović Z
    Z Geburtshilfe Neonatol; 2004 Oct; 208(5):197-202. PubMed ID: 15508054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twin pregnancy complicated by severe hemolytic disease of the fetus and newborn due to anti-g and anti-C.
    Trevett TN; Moise KJ
    Obstet Gynecol; 2005 Nov; 106(5 Pt 2):1178-80. PubMed ID: 16260562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with plasma exchange of a pregnant woman with anti-PP1Pk alloimmunization: A case report.
    Pignalosa O; Vigorita E; Capuano M; Caruso S; Mastroianni A; De Martino S; Vaccaro G; Meomartini D; Nocera C
    Transfus Apher Sci; 2024 Apr; 63(2):103871. PubMed ID: 38245405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of the test using polybrene for the detection of anti-erythrocyte antibodies].
    Lenkiewicz B
    Acta Haematol Pol; 1991; 22(1):127-35. PubMed ID: 1823954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hemolytic disease in a newborn infant caused by rare maternal anti-erythrocyte antibodies and exchange transfusion with maternal blood frozen earlier].
    Castel A; Drejer GF; Verwey RA
    Ned Tijdschr Geneeskd; 1993 Dec; 137(52):2713-5. PubMed ID: 8289944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serological investigation and clinical significance of high-titer, low-avidity (HTLA) antibodies.
    Moulds MK
    Am J Med Technol; 1981 Oct; 47(10):789-95. PubMed ID: 7199253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thrombocytic alloantigens and methods for their determination (significance of blood group serology)].
    Winter PM
    Wien Med Wochenschr; 1986 Feb; 136(3):57-63. PubMed ID: 2421491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and specificity of HLA antibodies in multitransfused patients with acquired aplastic anemia.
    Laundy GJ; Bradley BA; Rees BM; Younie M; Hows JM
    Transfusion; 2004 Jun; 44(6):814-25. PubMed ID: 15157245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the enzyme test for the detection of clinically significant red blood cell antibodies during pregnancy.
    Hundrić-Haspl Z; Juraković-Loncar N; Grgicević D
    Acta Med Croatica; 1999; 53(3):125-8. PubMed ID: 10705633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.